Assuntos
Hipotireoidismo Congênito , Animais , Diferenciação Celular/genética , Hipotireoidismo Congênito/diagnóstico , Hipotireoidismo Congênito/etiologia , Hipotireoidismo Congênito/terapia , Humanos , Sistema Hipotálamo-Hipofisário/fisiologia , Recém-Nascido , Proteínas de Membrana Transportadoras/genética , Transportadores de Ácidos Monocarboxílicos/genética , Mutação , Proteínas Nucleares/genética , Receptores do Hormônio Liberador da Tireotropina/genética , Transportadores de Sulfato , Simportadores , Glândula Tireoide/citologia , Glândula Tireoide/embriologia , Hormônios Tireóideos/biossíntese , Hormônios Tireóideos/fisiologia , Fator Nuclear 1 de Tireoide , Tireotropina Subunidade beta/deficiência , Tireotropina Subunidade beta/genética , Hormônio Liberador de Tireotropina/genética , Fatores de Transcrição/genéticaRESUMO
BACKGROUND: Thyroid hormones are crucial for normal growth and central nervous system development. In recent years, germline variants of the TSHbeta subunit gene have been identified as a cause of congenital TSH deficiency. METHODS: We performed a genetic and clinical study in children from four European countries diagnosed with congenital isolated central hypothyroidism. RESULTS: TSHbeta gene analysis revealed compound heterozygosity for 145C-->T (Q49X) and 313delT (C105Vfs114X) in 1 infant and homozygous mutation 313delT (C105Vfs114X) in 5 patients. Although all presented with typical symptoms of hypothyroidism, diagnosis and treatment was delayed until 3-5 months in 5 of 6 patients. In a longitudinal sibpair analysis, thyroxine substitution initiated immediately after birth was effective to prevent developmental delay and growth retardation. CONCLUSION: Clinical awareness is required to detect hypothyroidism due to TSHbeta mutations, which is not identified by TSH-based newborn screening. TSHbeta variants C105Vfs114X and Q49X are the most frequent cause of this severe disorder in Europe, now for the first time observed in compound heterozygous state.
Assuntos
Mutação em Linhagem Germinativa , Hipotireoidismo/genética , Tireotropina Subunidade beta/genética , Criança , Pré-Escolar , Hipotireoidismo Congênito , Europa (Continente) , Saúde da Família , Feminino , Genótipo , Transtornos do Crescimento/tratamento farmacológico , Transtornos do Crescimento/prevenção & controle , Heterozigoto , Homozigoto , Humanos , Hipotireoidismo/tratamento farmacológico , Recém-Nascido , Masculino , Triagem Neonatal , Linhagem , Tireotropina Subunidade beta/deficiência , Tiroxina/uso terapêuticoRESUMO
Newborn screening programs that use only high TSH levels as a marker for hypothyroidism may overlook neonates with congenital hypothyroidism (CH) due to TSH deficiency. We sought the cause of TSH deficiency in a neonate with low levels of thyroxine and TSH. The coding region of the TSHbeta gene was amplified and its sequence examined for mutations. Two mutations in exon 3 were identified: 1) a nucleotide deletion of T410 in codon 105 resulting in a frameshift in one allele, and 2) a previously unreported nucleotide deletion of T266 in codon 57, causing a frameshift and a premature stop at codon 62 in the other allele. We describe a compound heterozygous patient with TSHbeta mutations at codons 57 and 105 that interfered with a critical disulfide bond in the TSH molecule and caused CH. State screening programs that measure both T4 and TSH levels have the potential to detect newborns with congenital central hypothyroidism.
Assuntos
Hipotireoidismo Congênito , Hipotireoidismo/genética , Mutação , Tireotropina Subunidade beta/deficiência , Tireotropina Subunidade beta/genética , Fertilização in vitro , Heterozigoto , Terapia de Reposição Hormonal , Humanos , Hipotireoidismo/tratamento farmacológico , Recém-Nascido , Infusões Intravenosas , Masculino , Análise de Sequência de DNA , Tireotropina Subunidade beta/sangue , Hormônio Liberador de Tireotropina/farmacologia , Hormônio Liberador de Tireotropina/uso terapêutico , Tiroxina/sangue , Tiroxina/uso terapêutico , Fatores de Tempo , Resultado do TratamentoRESUMO
BACKGROUND: Congenital isolated thyrotropin (TSH) deficiency is an unusual condition characterized by low levels of thyroid hormones and TSH, usually presenting early typical signs of severe hypothyroidism. Five different beta-TSH mutations have been described so far. While 4 of them affect only consanguineous families, a frameshift mutation in exon 3 (C105fs114X) has been found also in nonconsanguineous families. OBJECTIVE: The aim of the present study was to characterize beta-TSH mutations in Argentinean patients with congenital central hypothyroidism (CCH) and to emphasize the importance of early biochemical and molecular diagnosis of this disorder. PATIENTS AND METHODS: We investigated 8 Argentinean children (3 boys, 5 girls) from 7 unrelated families with CCH based upon low levels of T(4) and T(3), and low basal and stimulated TSH levels. Mutation characterizations for the beta-TSH gene were performed by PCR amplification followed by sequence and restriction enzyme analysis with SNABI in the patients, 9 parents and in 100 newborn children. RESULTS: All patients presented the same homozygous mutation in exon 3 of the beta-TSH gene (C105fs114X), the 9 studied parents were heterozygous for the same mutation and 1 carrier was found in the 100 studied newborns. CONCLUSION: Our findings show that the C105fs114X mutation is prevalent in our population and may constitute a hot spot at codon 105 in the beta-TSH gene. Since this mutation is easily demonstrable by a SNABI digestion in DNA amplified from dried blood spots, its investigation would be indicated in patients in our milieu with clinical and biochemical features of CCH, allowing early L-thyroxine (LT(4)) replacement and genetic counseling of the family.
Assuntos
Mutação da Fase de Leitura , Hipotireoidismo/diagnóstico , Hipotireoidismo/genética , Tireotropina Subunidade beta/deficiência , Tireotropina Subunidade beta/genética , Criança , Hipotireoidismo Congênito , Análise Mutacional de DNA , Feminino , Homozigoto , Humanos , Recém-Nascido , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Mapeamento por Restrição , Análise de Sequência de DNARESUMO
Isolated congenital hypothyroidism resulting from mutation of the TSH beta-subunit gene, has rarely been reported. In the present article, we report a new mutation (C85R) in exon 3 of the TSH beta-subunit gene in one sporadic case and the mutation Q49stop in two siblings with congenital hypothyroidism. The novel mutation is a T to C transition at codon 85, resulting in a change of cysteine to arginine (C85R) of the ss-subunit. Because the cysteine residues of all glycoproteins are highly conserved, this mutation is expected to result in conformational changes of the ss-subunit, rendering it incapable to form a functional heterodimer with the alpha-subunit. The second mutation described is a C to T transition resulting in a premature stop at codon 49 (Q49stop), leading to the formation of a truncated protein. Although the two siblings reported herein carried the same mutation, they had slightly modified clinical and biochemical phenotype. The mutation C85R and the previously described E11stop have, thus far, exclusively been detected in Greek patients. The Q49stop mutation initially detected in Greek patients was subsequently identified in an Egyptian girl and most recently in two Turkish siblings. These three reports possibly indicate the presence of a mutational hot spot on the TSH beta-subunit gene. Hence, with the novel mutation herein reported, a total of five mutations of the TSH beta-subunit gene are recognized as a cause of low-TSH congenital hypothyroidism worldwide.